Emergency Help!
Advanced
Search
  1. Home
  2. Products
  3. VOTRIENT 200

VOTRIENT 200

VOTRIENT IS INDICATED FOR THE TREATMENT OF PATIENTS WITH ADVANCED RENAL CELL CARCINOMA (RCC). VOTRIENT IS INDICATED FOR THE TREATMENT OF PATIENTS WITH ADVANCED SOFT TISSUE SARCOMA (STS) WHO HAVE RECEIVED PRIOR CHEMOTHERAPY.

  • STRENGTH : 200 MG
  • PACKAGING SIZE : 120 TAB
  • COMPOSITION : PAZOPANIB
  • MANUFACTURER : NOVARTIS
Category: